| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 120 |
| 1 | VEDOLIZUMAB | 56 |
| 2 | INFLIXIMAB | 32 |
| 3 | PREDNISONE | 32 |
| 4 | ERGOCALCIFEROL | 27 |
| 5 | BEVACIZUMAB | 25 |
| 6 | FOLIC ACID | 25 |
| 7 | RISANKIZUMAB-RZAA | 25 |
| 8 | TEDUGLUTIDE | 23 |
| 9 | METHOTREXATE SODIUM | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | 1169 HYDROGEN PEROXIDE SPRAY | 1 | 0.0032 |
| 1 | HYDROGEN PEROXIDE | 1 | 0.0030 |
| 2 | INFLIXIMAB-DYYB | 8 | 0.0023 |
| 3 | TINIDAZOLE | 1 | 0.0023 |
| 4 | GAS RELIEF | 1 | 0.0020 |
| 5 | COLESEVELAM HYDROCHLORIDE | 2 | 0.0019 |
| 6 | ISRADIPINE | 1 | 0.0018 |
| 7 | TEDUGLUTIDE | 23 | 0.0017 |
| 8 | DOCUSATE SODIUM 50 MG SENNOSIDES 8.6 MG | 1 | 0.0013 |
| 9 | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | 1 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 58 |
| 1 | Integrin Receptor Antagonist [EPC] | 57 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 50 |
| 3 | Interleukin-23 Antagonist [EPC] | 43 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 40 |
| 5 | Proton Pump Inhibitor [EPC] | 31 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 30 |
| 7 | Vitamin C [EPC] | 29 |
| 8 | Provitamin D2 Compound [EPC] | 27 |
| 9 | Vitamin B12 [EPC] | 26 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | GLP-2 Analog [EPC] | 23 | 0.0017 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 2 | Provitamin D2 Compound [EPC] | 27 | 0.0009 |
| 3 | mu-Opioid Receptor Agonist [EPC] | 2 | 0.0007 |
| 4 | Integrin Receptor Antagonist [EPC] | 57 | 0.0007 |
| 5 | Cannabinoid [EPC] | 4 | 0.0005 |
| 6 | Interleukin-23 Antagonist [EPC] | 43 | 0.0004 |
| 7 | Glinide [EPC] | 3 | 0.0003 |
| 8 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 9 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |